LONG-ACTING AMYLIN RECEPTOR AGONIST
A long-acting amylin receptor agonist studied for appetite regulation and metabolic signaling pathways.
For research and laboratory use only.
Research Profile
Cagrilintide is explored for its interaction with amylin receptor pathways, commonly studied alongside GLP-1 compounds for metabolic research.
Studied for its interaction with amylin receptor signaling and appetite regulation mechanisms.
Explored in structured metabolic research protocols targeting energy balance.
Commonly studied alongside GLP-1 agonists for dual-pathway metabolic research.
Investigated for its role in satiety and appetite regulation pathways.
Size Options
Choose the size that fits your research protocol. All sizes undergo the same rigorous third-party testing.
Standard dosage for metabolic research protocols.
$0.00 Select — 10 mgQuality Assurance
Cagrilintide undergoes independent third-party laboratory analysis before distribution. Certificates of Analysis are available on request for every lot.
